PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12574206-5	2003	The NF-kappa B inhibitor, N-tosyl-L-phenylalanine chloromethyl ketone, reduced TNFalpha-induced IL-8 gene and protein expression.	Tosylphenylalanyl Chloromethyl Ketone	26-69	C-X-C motif chemokine ligand 8	Homo sapiens	96-100	
26418512-4	2016	Augmented IL-8 secretion by Ca9-22 cells was blocked by the NF-kappaB inhibitor L-1-4"-tosylamino-phenylethyl-chloromethyl ketone (TPCK) and the nicotinic acetylcholine receptor (nAChR)-specific inhibitor alpha-bungarotoxin (alphaBtx).	Tosylphenylalanyl Chloromethyl Ketone	131-135	C-X-C motif chemokine ligand 8	Homo sapiens	10-14	
19185596-9	2009	An NF-kappaB inhibitor, TPCK (N-Tosyl-L-Phenylalanine Chloromethyl Ketone) could suppress IL-8 production and secretion in response to S protein in PBMC and THP-1 cells and in HCoV-229E virus-infected PBMC.	Tosylphenylalanyl Chloromethyl Ketone	30-73	C-X-C motif chemokine ligand 8	Homo sapiens	90-94	
15618163-9	2005	The upregulation of ICAM-1, IL-6, and IL-8 was completely inhibited by pretreating the cells with an NF-kappaB activation inhibitor, l-1-tosylamido-2-phenylethyl chloromethyl ketone.	Tosylphenylalanyl Chloromethyl Ketone	133-181	C-X-C motif chemokine ligand 8	Homo sapiens	38-42	
12897563-11	2003	Treatment of cells with the NF-kappa B inhibitor N-tosyl-(L)-phenylalanine chloromethyl ketone, as well as with clarithromycin, reduced expression of IL-8 and NF-kappa B activity in a dose-dependent manner.	Tosylphenylalanyl Chloromethyl Ketone	49-94	C-X-C motif chemokine ligand 8	Homo sapiens	150-154	
9719033-6	1998	The IL-8 mRNA accumulation in response to P. intermedia LPS was inhibited by tosylphenyl-alanyl chloromethyl-ketone, an inhibitor of NF-kappaB activation, although the NF-kappaB activation itself was not altered by IFN-gamma.	Tosylphenylalanyl Chloromethyl Ketone	77-115	C-X-C motif chemokine ligand 8	Homo sapiens	4-8